VYD2311
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for VYD2311, covering 2024-11-19 to 2026-06-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of VYD2311 for the Prevention of COVID-19 [Phase 3]